elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33646955-42A76914-372B-460D-820C-58A4FD876FC7
Q33646955-42A76914-372B-460D-820C-58A4FD876FC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33646955-42A76914-372B-460D-820C-58A4FD876FC7
Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10
P2860
Q33646955-42A76914-372B-460D-820C-58A4FD876FC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33646955-42A76914-372B-460D-820C-58A4FD876FC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ab1352aa00eaa3e54e8656dc7fff7be498656d2
P2860
Selective ROCK2 inhibition in focal cerebral ischemia